References |
Top |
REF 1 |
The inhibitory effect of ErbB2 on epidermal growth factor-induced formation of clathrin-coated pits correlates with retention of epidermal growth factor receptor-ErbB2 oligomeric complexes at the plasma membrane. Mol Biol Cell. 2005 Dec;16(12):5832-42.
|
REF 2 |
Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity. Oncogene. 2009 Feb 12;28(6):803-14.
|
REF 3 |
Degradation of HER2 by Cbl-based chimeric ubiquitin ligases. Cancer Res. 2007 Sep 15;67(18):8716-24.
|
REF 4 |
Reciprocal regulation of Abl and receptor tyrosine kinases. Cell Signal. 2009 Jul;21(7):1143-50.
|
REF 5 |
Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. Cell. 2012 Aug 31;150(5):987-1001.
|
REF 6 |
ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner. J Biol Chem. 2002 Oct 11;277(41):38486-93.
|
REF 7 |
ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas. J Biol Chem. 2002 Jun 21;277(25):22692-8.
|
REF 8 |
Neuregulin-1 enhances survival of human astrocytic glioma cells. Glia. 2005 Aug 15;51(3):217-28.
|
REF 9 |
Neuregulin-1 enhances motility and migration of human astrocytic glioma cells. J Biol Chem. 2003 Jun 6;278(23):20971-8.
|
REF 10 |
A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature. 2006 Jan 12;439(7073):168-74.
|
REF 11 |
Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein. Mol Cancer Res. 2003 Aug;1(10):765-75.
|
REF 12 |
RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion. Oncogene. 2000 Mar 2;19(10):1318-28.
|
REF 13 |
c-erbB-2 gene product directly associates with beta-catenin and plakoglobin. Biochem Biophys Res Commun. 1995 Mar 28;208(3):1067-72.
|
REF 14 |
An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells. Oncogene. 2002 Jan 17;21(3):460-74.
|